Coleman, Daniel J.
Gao, Lina
King, Carly J.
Schwartzman, Jacob http://orcid.org/0000-0002-2640-8181
Urrutia, Joshua http://orcid.org/0000-0003-2171-0936
Sehrawat, Archana
Tayou, Junior
Balter, Ariel
Burchard, Julja
Chiotti, Kami E.
Derrick, Daniel S. http://orcid.org/0000-0003-3305-3507
Sun, Duanchen
Xia, Zheng http://orcid.org/0000-0003-3364-8324
Heiser, Laura M. http://orcid.org/0000-0003-3330-0950
Alumkal, Joshi J. http://orcid.org/0000-0003-1278-0166
Article History
Received: 9 November 2018
Revised: 15 March 2019
Accepted: 19 March 2019
First Online: 17 April 2019
Compliance with ethical standards
:
: JJA has performed consulting or held an advisory role with Astellas Pharma, Bayer, and Janssen Biotech, Inc. OHSU has received institutional research funding from Aragon Pharmaceuticals Inc., Astellas Pharma, Norvartis, Zenith Epigenetics Ltd, and Gilead Sciences Inc. These interests had no role in the design or conduct of this study. The remaining authors declare that they have no conflict of interest.